183 related articles for article (PubMed ID: 15688037)
1. Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo.
Fazi F; Travaglini L; Carotti D; Palitti F; Diverio D; Alcalay M; McNamara S; Miller WH; Lo Coco F; Pelicci PG; Nervi C
Oncogene; 2005 Mar; 24(11):1820-30. PubMed ID: 15688037
[TBL] [Abstract][Full Text] [Related]
2. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
3. Molecular signature of retinoic acid treatment in acute promyelocytic leukemia.
Meani N; Minardi S; Licciulli S; Gelmetti V; Coco FL; Nervi C; Pelicci PG; Müller H; Alcalay M
Oncogene; 2005 May; 24(20):3358-68. PubMed ID: 15735696
[TBL] [Abstract][Full Text] [Related]
4. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
5. PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter.
Tabe Y; Konopleva M; Kondo Y; Contractor R; Jin L; Ruvolo V; Tsutsumi-Ishii Y; Miyake K; Miyake N; Ohsaka A; Nagaoka I; Issa JP; Andreeff M
Ann Hematol; 2006 Oct; 85(10):689-704. PubMed ID: 16832676
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?
Minucci S; Nervi C; Lo Coco F; Pelicci PG
Oncogene; 2001 May; 20(24):3110-5. PubMed ID: 11420727
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C
Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810
[TBL] [Abstract][Full Text] [Related]
8. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response.
Grignani F; Gelmetti V; Fanelli M; Rogaia D; De Matteis S; Ferrara FF; Bonci D; Grignani F; Nervi C; Pelicci PG
Oncogene; 1999 Nov; 18(46):6313-21. PubMed ID: 10597230
[TBL] [Abstract][Full Text] [Related]
9. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
Savickiene J; Treigyte G; Magnusson KE; Navakauskiene R
Ann N Y Acad Sci; 2009 Aug; 1171():321-33. PubMed ID: 19723072
[TBL] [Abstract][Full Text] [Related]
10. [Acute promyelocytic leukemia, histone deacetylase, and response to retinoids].
Jeanteur P
Bull Cancer; 1998 Apr; 85(4):301-3. PubMed ID: 9752292
[TBL] [Abstract][Full Text] [Related]
11. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor.
Di Croce L; Raker VA; Corsaro M; Fazi F; Fanelli M; Faretta M; Fuks F; Lo Coco F; Kouzarides T; Nervi C; Minucci S; Pelicci PG
Science; 2002 Feb; 295(5557):1079-82. PubMed ID: 11834837
[TBL] [Abstract][Full Text] [Related]
12. Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells.
Côté S; Rosenauer A; Bianchini A; Seiter K; Vandewiele J; Nervi C; Miller WH
Blood; 2002 Oct; 100(7):2586-96. PubMed ID: 12239173
[TBL] [Abstract][Full Text] [Related]
13. Retinoids and differentiation treatment: a strategy for treatment in cancer.
Cornic M; Agadir A; Degos L; Chomienne C
Anticancer Res; 1994; 14(6A):2339-46. PubMed ID: 7825969
[TBL] [Abstract][Full Text] [Related]
14. Pro-proliferative function of the long isoform of PML-RARalpha involved in acute promyelocytic leukemia.
Tussié-Luna MI; Rozo L; Roy AL
Oncogene; 2006 Jun; 25(24):3375-86. PubMed ID: 16434964
[TBL] [Abstract][Full Text] [Related]
15. The methyl-CpG binding protein MBD1 is required for PML-RARalpha function.
Villa R; Morey L; Raker VA; Buschbeck M; Gutierrez A; De Santis F; Corsaro M; Varas F; Bossi D; Minucci S; Pelicci PG; Di Croce L
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1400-5. PubMed ID: 16432238
[TBL] [Abstract][Full Text] [Related]
16. Alteration in the cellular response to retinoic acid of a human acute promyelocytic leukemia cell line, UF-1, carrying a patient-derived mutant PML-RARalpha chimeric gene.
Sato A; Imaizumi M; Hoshi Y; Rikiishi T; Fujii K; Kizaki M; Kagechika H; Kakizuka A; Hayashi Y; Iinuma K
Leuk Res; 2004 Sep; 28(9):959-67. PubMed ID: 15234573
[TBL] [Abstract][Full Text] [Related]
17. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
18. New role for granulocyte colony-stimulating factor-induced extracellular signal-regulated kinase 1/2 in histone modification and retinoic acid receptor α recruitment to gene promoters: relevance to acute promyelocytic leukemia cell differentiation.
Cassinat B; Zassadowski F; Ferry C; Llopis L; Bruck N; Lainey E; Duong V; Cras A; Despouy G; Chourbagi O; Beinse G; Fenaux P; Rochette Egly C; Chomienne C
Mol Cell Biol; 2011 Apr; 31(7):1409-18. PubMed ID: 21262770
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.
Ferrara FF; Fazi F; Bianchini A; Padula F; Gelmetti V; Minucci S; Mancini M; Pelicci PG; Lo Coco F; Nervi C
Cancer Res; 2001 Jan; 61(1):2-7. PubMed ID: 11196162
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays.
Nouzova M; Holtan N; Oshiro MM; Isett RB; Munoz-Rodriguez JL; List AF; Narro ML; Miller SJ; Merchant NC; Futscher BW
J Pharmacol Exp Ther; 2004 Dec; 311(3):968-81. PubMed ID: 15302897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]